Tirzepatide
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Eli Lilly · Phase 3 · Recruiting · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 76 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 76 | n/r | n/r |